Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo Vernia

Showing results (1-10 of 30) with videos related to

Pageof 3
Sort By:
Journal of Clinical Medicine|July 27, 2024
IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or ReinductionFilippo Vernia, Sabrina Monaco, Giovanni Latella
Journal of Clinical Apheresis|October 3, 2023
Adsorptive cytapheresis in ulcerative colitis: A non-pharmacological therapeutic approach revisitedFilippo Vernia, Angelo Viscido, Giovanni Latella
Journal of Clinical Medicine|May 14, 2025
Nutritional Deficiencies and Reduced Bone Mineralization in Ulcerative ColitisFilippo Vernia, Emanuela Ribichini, Giorgia Burrelli Scotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2020
Early hydrogen excretion peaks during breath tests. Small intestinal bacterial overgrowth or accelerated transit?Piero Vernia, Monica Cesarini, Aurora de Carolis, et al.
Nutrients|January 6, 2021
Dietary Factors Modulating Colorectal CarcinogenesisFilippo Vernia, Salvatore Longo, Gianpiero Stefanelli, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Correction: Vernia et al. Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered. <i>Medicina</i> 2024, <i>60</i>, 57Filippo Vernia, Laura Cirella, Giuseppe Calvisi, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be ConsideredFilippo Vernia, Laura Cirella, Giuseppe Calvisi, et al.
Inflammatory Bowel Diseases|December 23, 2017
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?Mirko Di Ruscio, Filippo Vernia, Antonio Ciccone, et al.
Nutrients|January 21, 2022
Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic ImplicationsFilippo Vernia, Marco Valvano, Salvatore Longo, et al.
Digestion|September 14, 2021
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role?Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, et al.
Pageof 3

Showing results (1-10 of 30) with videos related to

Sort By:
Pageof 3
Journal of Clinical Medicine|July 27, 2024
IBD Patients with Primary or Secondary Nonresponse to Ustekinumab Benefit from Dose Escalation or ReinductionFilippo Vernia, Sabrina Monaco, Giovanni Latella
Journal of Clinical Apheresis|October 3, 2023
Adsorptive cytapheresis in ulcerative colitis: A non-pharmacological therapeutic approach revisitedFilippo Vernia, Angelo Viscido, Giovanni Latella
Journal of Clinical Medicine|May 14, 2025
Nutritional Deficiencies and Reduced Bone Mineralization in Ulcerative ColitisFilippo Vernia, Emanuela Ribichini, Giorgia Burrelli Scotti, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|September 2, 2020
Early hydrogen excretion peaks during breath tests. Small intestinal bacterial overgrowth or accelerated transit?Piero Vernia, Monica Cesarini, Aurora de Carolis, et al.
Nutrients|January 6, 2021
Dietary Factors Modulating Colorectal CarcinogenesisFilippo Vernia, Salvatore Longo, Gianpiero Stefanelli, et al.
Medicina (Kaunas, Lithuania)|March 28, 2026
Correction: Vernia et al. Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be Considered. <i>Medicina</i> 2024, <i>60</i>, 57Filippo Vernia, Laura Cirella, Giuseppe Calvisi, et al.
Medicina (Kaunas, Lithuania)|January 23, 2024
Immunoglobulin G4-Related Disease of the Intestine: A Clinicopathological Entity to Be ConsideredFilippo Vernia, Laura Cirella, Giuseppe Calvisi, et al.
Inflammatory Bowel Diseases|December 23, 2017
Surrogate Fecal Biomarkers in Inflammatory Bowel Disease: Rivals or Complementary Tools of Fecal Calprotectin?Mirko Di Ruscio, Filippo Vernia, Antonio Ciccone, et al.
Nutrients|January 21, 2022
Vitamin D in Inflammatory Bowel Diseases. Mechanisms of Action and Therapeutic ImplicationsFilippo Vernia, Marco Valvano, Salvatore Longo, et al.
Digestion|September 14, 2021
Fecal Lactoferrin and Other Putative Fecal Biomarkers in Crohn's Disease: Do They Still Have a Potential Clinical Role?Filippo Vernia, Angelo Viscido, Mirko Di Ruscio, et al.
Pageof 3